A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: 9d95e953e635302fc21772cf3f17f1a72c48e5a4
First added on: Apr 16, 2025